Testing a glowing dye to find nervous system tumor tissue
Part of Brain & nervous system, Cancer clinical trials.
This early (Phase 1) study tests whether a glowing dye called indocyanine green helps surgeons better see nervous system tumor tissue during an operation, with the goal of lowering the chance of tumor coming back locally. It’s for adults whose tumor is expected to be removable and at risk for local recurrence.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult age 18 or older.
- Your doctor thinks you have a nervous system tumor that can likely be surgically removed.
- Your surgical team (doctors and specialists working together) believes you are a good candidate for surgery.
- You are able to understand the study and sign informed consent.
- You are not pregnant around the time of surgery (pregnancy testing within 48 hours).
- You have no known allergy to iodide (iodine-containing allergy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.
This early-phase study tests whether a special dye can help doctors see a tumor more clearly during surgery in children and young people. If you have a solid tumor or certain lymphomas that need removal, the dye may help guide the surgeon to the right tissue.
This trial tests whether a special dye called ICG, which glows under infrared light, can help surgeons better see and remove bone and soft tissue tumors during surgery. The goal is to make the removal more precise and safe.
This trial uses a special dye called ICG that makes cancer glow under a special camera during breast cancer surgery. Doctors want to find the best time to give the dye so they can see the cancer clearly and remove all of it in one operation.
This trial tests whether a special dye (ICG) seen during your surgery can help doctors better identify the edges of a tumor in bone or soft tissue. It may help ensure as much of the tumor is removed as safely as possible.
This trial tests a device (CCeLL-In Vivo) that may help surgeons tell tumor from normal brain tissue during an operation, which could improve how much tumor is removed while protecting healthy brain.
Hear when a new Nervous System Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.